CHASKA, Minn.--(BUSINESS WIRE)--LIFECORE BIOMEDICAL, INC. (NASDAQ:LCBM) announced today that it has renewed its manufacturing agreement with Alcon Pharmaceuticals, Ltd., a subsidiary of Alcon, Inc. (NYSE:ACL), the world’s leading eye care company. Lifecore supplies hyaluronan to Alcon for use in Viscoat® ophthalmic viscoelastic solution, which doctors use in eye surgeries such as cataract extraction and intraocular lens implantation. The new agreement extends through December, 2013 and retains minimum purchase commitments and other features of the previous agreement. “Renewal of the agreement extends Lifecore’s long-standing relationship with our largest customer and the leader in the ophthalmic market,” said Lifecore President and CEO, Dennis J. Allingham. “We are pleased that the renewal term has been extended by five years, and believe it provides another strong indication of Lifecore’s commitment and capability to secure and hold partnerships with medical market leaders.“
